Tendonitis Treatment

Tendonitis Treatment Market Outlook

The global tendonitis treatment market is projected to reach approximately USD 4.5 billion by 2025, with a compound annual growth rate (CAGR) of 6.2% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of tendonitis across various demographics, particularly among athletes and older adults who are more susceptible to this condition. The rising awareness regarding preventive care and advancements in treatment modalities, such as physical therapy and orthotic devices, contribute significantly to market expansion. Additionally, the growing focus on rehabilitation and recovery processes in medical facilities enhances the demand for effective tendonitis treatments. Overall, the market is expected to witness substantial growth due to the advancing healthcare infrastructure and the introduction of innovative treatment solutions.

Growth Factor of the Market

Several factors contribute to the growth of the tendonitis treatment market, highlighting the increasing demand for effective therapeutic options. First, the rising incidence of sports-related injuries, particularly among young athletes, creates a significant need for specialized treatments for tendonitis. Additionally, the growing aging population is more prone to degenerative conditions, including tendonitis, thereby driving market growth as older individuals seek relief from chronic pain and mobility issues. The expansion of healthcare facilities, including rehabilitation centers and outpatient surgical centers, also facilitates easier access to advanced treatment options. Furthermore, awareness campaigns aimed at educating the population about tendonitis prevention and management are essential in fostering proactive healthcare behaviors. Lastly, technological advancements in treatment modalities, such as minimally invasive surgeries and innovative physiotherapy techniques, enhance the overall efficacy of tendonitis treatment, further augmenting market growth.

Key Highlights of the Market

• The tendonitis treatment market is anticipated to grow at a CAGR of 6.2% from 2025 to 2035.
• Increasing prevalence of tendonitis among athletes and aging individuals is a primary growth driver.
• Enhanced technological advancements in treatment options significantly boost market dynamics.
• Rehabilitation and outpatient services are expanding access to treatment and recovery.
• Rising awareness of preventive healthcare measures and rehabilitation strategies are enhancing treatment adherence.

By Treatment Type

Physical Therapy:

Physical therapy plays a pivotal role in the treatment of tendonitis, as it focuses on rehabilitation and functional recovery. Techniques employed in physical therapy include stretching, strengthening exercises, and modalities that promote tissue healing. Patients undergoing physical therapy benefit from personalized treatment plans that address their specific conditions, which can reduce pain and improve mobility significantly. Physical therapy is especially effective in treating tendonitis because it helps to restore the normal function of the affected tendon and surrounding tissues. The growing preference for non-invasive treatment options among patients is further driving the adoption of physical therapy, making it a crucial segment in the tendonitis treatment market.

Medications:

Medications, including non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, are commonly used to alleviate pain and inflammation associated with tendonitis. These pharmaceuticals are often administered alongside other treatment modalities to enhance overall efficacy. NSAIDs like ibuprofen and naproxen are popular choices due to their ability to reduce swelling and provide pain relief. In cases where inflammation is severe, corticosteroid injections may be considered for localized relief. The segment is expected to see growth as more individuals opt for quick pain management solutions, although there is a growing emphasis on addressing the underlying causes of tendonitis through comprehensive treatment approaches.

Orthotic Devices:

Orthotic devices, including braces and supports, are essential in the conservative management of tendonitis. By providing stabilization and reducing stress on the affected tendon, these devices facilitate the healing process. The increasing availability of custom-made orthotics tailored to individual needs further enhances their effectiveness. Additionally, the growing awareness regarding the role of orthotics in injury prevention and rehabilitation contributes to the segment's growth. As more patients seek to prevent recurrences of tendonitis, the demand for effective orthotic solutions is expected to rise, solidifying their importance within the tendonitis treatment landscape.

Shockwave Therapy:

Shockwave therapy is an innovative treatment option for tendonitis that utilizes acoustic waves to promote tissue healing and reduce pain. This non-invasive procedure has gained popularity due to its effectiveness, particularly for chronic cases that haven’t responded well to conventional treatments. By stimulating blood circulation and the healing process in the affected tendon, shockwave therapy helps to accelerate recovery times. As more healthcare professionals adopt this modern treatment approach, the segment is anticipated to grow. Patients and practitioners alike appreciate the benefits of shockwave therapy, which include minimal downtime and a lower risk of complications compared to surgical options.

Surgery:

Surgery is often considered a last resort in the management of tendonitis, reserved for cases where conservative treatments have failed. Surgical options may vary depending on the severity and specific location of the tendonitis but typically involve repairing the damaged tendon or removing inflamed tissue. With advancements in minimally invasive surgical techniques, recovery times have decreased, making surgical interventions more appealing to patients. Moreover, the rising prevalence of severe tendonitis cases among the aging population is likely to increase the demand for surgical treatments. As healthcare providers continue to enhance surgical outcomes, this segment is positioned for growth within the tendonitis treatment market.

By Body Part

Shoulder:

Tendonitis of the shoulder, often referred to as rotator cuff tendonitis, is prevalent among individuals who engage in repetitive overhead activities. This condition can lead to significant discomfort and limited range of motion, affecting daily activities and quality of life. Treatment options for shoulder tendonitis typically include a combination of physical therapy, medication, and in some cases, surgical intervention. The growing number of patients suffering from shoulder tendonitis, particularly athletes and manual laborers, is driving the demand for targeted treatment options. As awareness increases regarding the importance of early intervention, the shoulder segment of the tendonitis treatment market is expected to expand.

Elbow:

Elbow tendonitis, commonly known as tennis elbow or golfer's elbow, is a condition that results from overuse or repetitive strain on the tendons around the elbow joint. This ailment is particularly prevalent in sports enthusiasts and individuals involved in occupations that demand repetitive arm motions. The treatment for elbow tendonitis often includes physical therapy, rest, and the use of orthotic devices to limit strain on the elbow. As the emphasis on sports participation grows, especially in recreational activities, the incidence of elbow tendonitis is likely to rise, thus expanding the market for effective treatment options in this segment.

Knee:

Knee tendonitis, or patellar tendonitis, is a common injury among athletes, particularly those involved in jumping sports. This condition is characterized by pain and inflammation around the kneecap, leading to functional limitations. Treatment for knee tendonitis typically involves physical therapy, bracing, and in some severe cases, surgical intervention. With the increasing popularity of high-intensity sports and recreational activities, the prevalence of knee tendonitis is on the rise. Consequently, the demand for effective treatments is expected to grow in this segment as healthcare providers seek to address the specific needs of affected individuals.

Wrist:

Wrist tendonitis, often referred to as De Quervain's tenosynovitis, arises from repetitive thumb and wrist motions, commonly seen in activities like texting or playing certain sports. Patients typically experience pain along the thumb side of the wrist, which can significantly impede daily tasks. Treatment strategies usually include rest, physical therapy, and the use of orthotic devices to alleviate strain. With the increasing reliance on technology and mobile devices, the incidence of wrist tendonitis is likely to rise, thereby driving growth in this treatment segment. Healthcare providers are adapting to these trends by developing targeted interventions that address wrist tendonitis effectively.

Ankle:

Ankle tendonitis often results from overuse or injury to the tendons surrounding the ankle joint, leading to pain and swelling. This condition is particularly prevalent among athletes and individuals who perform repetitive ankle movements. Treatment typically involves physical therapy, rest, and orthotic support to stabilize the joint. As sports participation continues to grow, especially in activities that place significant stress on the ankle, the incidence of ankle tendonitis is expected to rise. Consequently, the market for treatment options specific to ankle tendonitis is poised for growth as healthcare providers focus on effective management strategies.

By User

Hospitals:

Hospitals are a primary setting for tendonitis treatment, offering comprehensive care across various specialties. The presence of multidisciplinary teams enables hospitals to provide a broad range of treatment options, including medications, physical therapy, and surgical interventions. As the demand for tendonitis treatment increases, hospitals are expanding their orthopedic and rehabilitation services, ensuring patients receive effective and timely care. Furthermore, the integration of technology in hospitals, such as telemedicine and advanced diagnostic tools, enhances patient experience and treatment outcomes, making hospitals a crucial player in the tendonitis treatment market.

Orthopedic Clinics:

Orthopedic clinics specialize in the diagnosis and treatment of musculoskeletal conditions, including tendonitis. They offer tailored treatment plans that focus on both immediate relief and long-term recovery. These clinics often employ a variety of treatment modalities, such as physical therapy, medication management, and, when necessary, surgical procedures. Patients seeking specialized care for tendonitis are increasingly turning to orthopedic clinics, which provide a more personalized approach compared to general healthcare providers. As the demand for specialized orthopedic care rises, these clinics are expected to play a crucial role in the tendonitis treatment market.

Rehabilitation Centers:

Rehabilitation centers focus on recovery and rehabilitation for individuals with musculoskeletal injuries, including tendonitis. These facilities provide comprehensive treatment programs that combine physical therapy, occupational therapy, and pain management strategies. The increasing recognition of the importance of rehabilitation in the recovery process is driving the demand for services offered by rehabilitation centers. As more patients seek holistic approaches to healing, rehabilitation centers are becoming critical in delivering effective management for tendonitis, thus contributing significantly to this segment of the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as a popular choice for outpatient procedures, including surgeries for tendonitis. These facilities offer a convenient and cost-effective alternative to traditional hospital settings for patients undergoing minimally invasive procedures. The preference for outpatient care is increasing, driven by advancements in surgical technology and anesthesia, which allow for faster recovery times. ASCs are well-equipped to provide specialized care for tendonitis, enhancing patient satisfaction and reducing overall healthcare costs. As the trend towards outpatient services continues, ASCs are likely to play a growing role in the tendonitis treatment market.

By Cause

Overuse:

Overuse is one of the most common causes of tendonitis, often resulting from repetitive motions that place excessive strain on the tendons. Athletes, manual laborers, and individuals engaged in repetitive tasks are particularly susceptible to developing tendonitis due to overuse. Treatment typically focuses on rest, physical therapy, and pain management strategies. The growing participation in sports and physical activities is likely to drive the incidence of overuse-related tendonitis cases, consequently increasing the demand for effective treatment options. As awareness of overuse injuries rises, healthcare providers are adapting their approaches to address this prevalent cause of tendonitis.

Injury:

Acute injuries can lead to tendonitis, as a sudden trauma or strain can cause inflammation and damage to the affected tendons. This type of tendonitis often requires a more immediate response, including rest, ice application, and medical intervention. Athletes and active individuals are particularly at risk of injury-related tendonitis, as they may engage in high-impact activities. The increasing focus on injury prevention and management in sports is driving growth in the treatment of injury-related tendonitis. As more patients seek prompt care after sustaining injuries, the demand for specialized treatment options in this segment is expected to rise.

Aging:

Aging is a significant factor contributing to the development of tendonitis, as the body's natural ability to heal and recover diminishes over time. Older adults are more likely to experience degenerative changes in their tendons, leading to inflammation and pain. Treatment for aging-related tendonitis often involves a multidisciplinary approach that addresses both the underlying degenerative processes and symptom relief. The growing aging population is creating a larger patient base for tendonitis treatment, prompting healthcare providers to develop targeted strategies for managing this condition in older adults. As the demand for geriatric care increases, the aging segment is set to see substantial growth within the tendonitis treatment market.

Medical Conditions:

Certain medical conditions, such as diabetes, arthritis, and hormonal imbalances, can predispose individuals to tendonitis. Patients with these underlying health issues may experience tendonitis as a secondary complication, necessitating a comprehensive treatment approach that addresses both the tendonitis and the underlying condition. Healthcare providers are increasingly recognizing the importance of addressing comorbidities when treating tendonitis, leading to more holistic treatment plans. As the prevalence of chronic medical conditions rises, the market for treating tendonitis related to these issues is expected to grow, with an emphasis on integrated care strategies.

By Region

The tendonitis treatment market is witnessing significant regional variations driven by factors such as healthcare infrastructure, population demographics, and awareness levels regarding tendonitis management. North America dominates the market, accounting for approximately 40% of the global share, primarily due to the high prevalence of tendonitis and advanced healthcare facilities available in this region. The market in North America is projected to grow at a CAGR of 6.5% from 2025 to 2035, driven by the increasing adoption of innovative treatment options and the rising incidence of sports-related injuries. Europe follows closely, holding around 30% of the market share, with countries like Germany and the UK leading the way in tendonitis treatment advancements.

In the Asia Pacific region, the tendonitis treatment market is expected to grow rapidly, with a CAGR of 7.0% from 2025 to 2035. This growth is driven by the increasing awareness of orthopedic conditions and the expansion of healthcare infrastructure in countries such as China and India. The Latin America and Middle East & Africa regions represent smaller market shares, accounting for approximately 20% and 10%, respectively. However, these regions are also projected to witness gradual growth as healthcare access improves and awareness of tendonitis treatment options increases among the populations. Overall, the regional analysis indicates a positive outlook for the tendonitis treatment market, highlighting opportunities for growth across various regions.

Opportunities

The tendonitis treatment market presents multiple opportunities for growth, particularly in the area of innovative treatment modalities. The development of new technologies, such as regenerative medicine and biologic therapies, holds promise for enhancing recovery rates and reducing treatment times for tendonitis patients. Advanced treatments that leverage stem cell therapy or platelet-rich plasma (PRP) injections are gaining traction, offering a potential alternative to conventional therapies. As research continues to evolve, the introduction of these cutting-edge technologies can significantly enhance treatment effectiveness, appealing to both healthcare providers and patients seeking improved outcomes. Additionally, the increasing focus on preventive healthcare measures can further drive growth, as individuals become more proactive in managing their musculoskeletal health and reducing the risk of tendonitis.

Furthermore, the rise of telemedicine and digital health solutions presents significant opportunities for the tendonitis treatment market. With the ongoing digital transformation in healthcare, patients can access treatment advice and follow-up consultations online, making healthcare more accessible. Telehealth platforms can facilitate remote physical therapy sessions, allowing patients to receive guidance and support from professionals without the need for in-person visits. This trend is particularly beneficial for individuals in rural or underserved areas where specialized care may be limited. As telehealth continues to gain traction, the tendonitis treatment market can capitalize on this opportunity by integrating digital solutions into their services, thereby enhancing patient engagement and adherence to treatment protocols.

Threats

Despite the promising growth of the tendonitis treatment market, several threats could hinder market progress. One significant threat is the increasing competition from alternative therapies and treatments, such as traditional medicine practices, that patients may seek instead of conventional treatments. Patients often explore holistic or alternative approaches, leading to a shift in treatment preferences and potentially impacting the demand for standard tendonitis treatments. Additionally, economic downturns and fluctuations in healthcare spending can pose challenges for the market, as patients may delay or forgo treatments due to financial constraints. Healthcare providers must remain vigilant to these competing influences while continuing to demonstrate the efficacy and value of conventional tendonitis treatments to maintain their market share.

Moreover, regulatory hurdles and the lengthy approval process for new treatment options can also act as a restraining factor in the tendonitis treatment market. Innovations in treatment modalities may take considerable time to receive regulatory clearance, which can delay their introduction into the market. This lag can hinder the overall growth of the market, as healthcare providers and patients may experience a lack of access to the latest advancements in tendonitis treatment. To navigate these challenges, stakeholders in the tendonitis treatment market must invest in strategic partnerships and collaborations that facilitate efficient research and development processes while ensuring compliance with regulatory standards.

Competitor Outlook

• PhysioTherapy Associates
• Hanger Clinic
• Medtronic
• Zimmer Biomet
• U.S. Physical Therapy, Inc.
• Smith & Nephew
• BioCare Copenhagen
• Regeneron Pharmaceuticals
• Stryker Corporation
• Abbott Laboratories
• Orthofix International N.V.
• Halyard Health
• Richmond Physical Therapy
• Thermo Fisher Scientific
• Allergan, Inc.

The competitive landscape of the tendonitis treatment market is characterized by a diverse range of players, including multinational corporations, specialized clinics, and emerging startups. Major pharmaceutical companies, such as Medtronic and Smith & Nephew, are investing heavily in research and development to innovate new therapeutic solutions that address tendonitis effectively. These companies leverage their extensive resources and expertise to create comprehensive treatment options, which include medications and advanced surgical techniques. Furthermore, the increasing emphasis on personalized medicine and patient-centered care is prompting these corporations to collaborate with orthopedic specialists and rehabilitation experts to develop targeted treatment plans that cater to individual patient needs.

Additionally, many companies are focusing on expanding their presence in emerging markets, which offer untapped potential for growth. As the global healthcare landscape evolves, organizations are adapting their strategies to meet the unique needs of different regions. This includes tailoring treatment options based on regional demographics and healthcare infrastructures. For instance, companies like Zimmer Biomet and Orthofix International are actively exploring partnerships with local healthcare providers to enhance access to tendonitis treatments in underserved areas. These strategic moves aim to strengthen their market position and drive revenue growth while addressing the increasing demand for effective tendonitis management solutions.

In summary, the tendonitis treatment market is marked by a competitive environment where both established players and new entrants are striving to gain market share. The focus on technological advancements, personalized care, and regional expansion positions key players well to capitalize on emerging opportunities. As the market continues to grow, collaboration between healthcare providers, researchers, and pharmaceutical companies is essential to drive innovation and improve patient outcomes. Companies that remain agile and responsive to changing market dynamics will be best positioned for long-term success in the tendonitis treatment market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hanger Clinic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Zimmer Biomet
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Allergan, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Halyard Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 BioCare Copenhagen
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 PhysioTherapy Associates
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Regeneron Pharmaceuticals
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Richmond Physical Therapy
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Orthofix International N.V.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 U.S. Physical Therapy, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Tendonitis Treatment Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Orthopedic Clinics
    • 6.1.3 Rehabilitation Centers
    • 6.1.4 Ambulatory Surgical Centers
  • 6.2 Tendonitis Treatment Market, By Cause
    • 6.2.1 Overuse
    • 6.2.2 Injury
    • 6.2.3 Aging
    • 6.2.4 Medical Conditions
  • 6.3 Tendonitis Treatment Market, By Body Part
    • 6.3.1 Shoulder
    • 6.3.2 Elbow
    • 6.3.3 Knee
    • 6.3.4 Wrist
    • 6.3.5 Ankle
  • 6.4 Tendonitis Treatment Market, By Treatment Type
    • 6.4.1 Physical Therapy
    • 6.4.2 Medications
    • 6.4.3 Orthotic Devices
    • 6.4.4 Shockwave Therapy
    • 6.4.5 Surgery

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Tendonitis Treatment Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Tendonitis Treatment market is categorized based on

By Treatment Type

• Physical Therapy
• Medications
• Orthotic Devices
• Shockwave Therapy
• Surgery

By Body Part

• Shoulder
• Elbow
• Knee
• Wrist
• Ankle

By User

• Hospitals
• Orthopedic Clinics
• Rehabilitation Centers
• Ambulatory Surgical Centers

By Cause

• Overuse
• Injury
• Aging
• Medical Conditions

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• PhysioTherapy Associates
• Hanger Clinic
• Medtronic
• Zimmer Biomet
• U.S. Physical Therapy, Inc.
• Smith & Nephew
• BioCare Copenhagen
• Regeneron Pharmaceuticals
• Stryker Corporation
• Abbott Laboratories
• Orthofix International N.V.
• Halyard Health
• Richmond Physical Therapy
• Thermo Fisher Scientific
• Allergan, Inc.